We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+27.17%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$3.85B
AUM Growth
+$2.03B
Cap. Flow
+$1.66B
Cap. Flow %
43.05%
Top 10 Hldgs %
17.46%
Holding
2,172
New
1,142
Increased
418
Reduced
161
Closed
448

Sector Composition

Rank Sector Weight
1 Technology 15.36%
2 Healthcare 10.23%
3 Industrials 9.8%
4 Financials 9.25%
5 Consumer Discretionary 7.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKU icon
1776
Bankunited
BKU
$3.3B
-21,616
Closed -$404K
BP icon
1777
BP
BP
$115B
-26,543
Closed -$647K
BR icon
1778
Broadridge
BR
$20.8B
-9,742
Closed -$924K
BRW
1779
Saba Capital Income & Opportunities Fund
BRW
$327M
-10,525
Closed -$78K
BTZ icon
1780
BlackRock Credit Allocation Income Trust
BTZ
$947M
-18,943
Closed -$221K
CABA icon
1781
Cabaletta Bio
CABA
$531M
-15,668
Closed -$114K
CAKE icon
1782
Cheesecake Factory
CAKE
$5.64B
-13,688
Closed -$234K
CASY icon
1783
Casey's General Stores
CASY
$30.9B
-4,662
Closed -$618K
CCAP icon
1784
Crescent Capital BDC
CCAP
$395M
-10,070
Closed -$97K
CCI icon
1785
Crown Castle
CCI
$32.1B
-5,510
Closed -$796K
CCIF
1786
Carlyle Credit Income Fund
CCIF
$57.9M
-14,261
Closed -$120K
CCL icon
1787
Carnival Corporation Ltd
CCL
$35.2B
-23,321
Closed -$307K
CCOI icon
1788
Cogent Communications
CCOI
$470M
-2,702
Closed -$221K
CCRN
1789
DELISTED
Cross Country Healthcare
CCRN
-14,864
Closed -$100K
CDE icon
1790
Coeur Mining
CDE
$21.6B
-126,341
Closed -$406K
CDLX icon
1791
Cardlytics
CDLX
$25.3M
-1,966
Closed -$687K
CDTX
1792
DELISTED
Cidara Therapeutics
CDTX
-812
Closed -$40K
CFG icon
1793
Citizens Financial Group
CFG
$29.4B
-77,850
Closed -$1.46M
CG icon
1794
Carlyle Group
CG
$17.6B
-410,993
Closed -$8.9M
CFR icon
1795
Cullen/Frost Bankers
CFR
$10.2B
-5,220
Closed -$291K
CIEN icon
1796
Ciena
CIEN
$56B
-13,178
Closed -$525K
CKPT
1797
DELISTED
Checkpoint Therapeutics
CKPT
-1,365
Closed -$21K
CMI icon
1798
Cummins
CMI
$80.9B
-3,786
Closed -$512K
CMS icon
1799
CMS Energy
CMS
$21.4B
-31,197
Closed -$1.83M
CNA icon
1800
CNA Financial
CNA
$13.3B
-15,196
Closed -$472K

Similar funds

Michael Gelband's Q2 2020 Portfolio in Review

As of Q2 2020, Michael Gelband held 2,172 positions worth $3.85B, up 111% from $1.82B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Michael Gelband deployed $1.66B of net new capital in Q2 2020, opening 1,142 new positions and adding to 418 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 266,338 shares worth $82.1M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 12% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Amazon, an estimated $27.8M trimmed.

  • Michael Gelband's largest Q2 2020 buy was State Street SPDR S&P 500 ETF Trust: 266,338 shares worth $82.1M.
  • Michael Gelband added most to PG&E in Q2 2020, an estimated $38.2M increase.
  • Michael Gelband's biggest Q2 2020 reduction was Amazon, cutting an estimated $27.8M.
  • Michael Gelband fully exited McKesson in Q2 2020, selling an estimated $18.1M.
  • Michael Gelband's ten largest holdings make up 17% of its $3.85B portfolio in Q2 2020.
  • Michael Gelband opened 1,142 new positions and closed 448 in Q2 2020.
  • Michael Gelband's portfolio value rose 111% quarter-over-quarter to $3.85B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.